| Literature DB >> 20460541 |
Jae Ho Lee1, Cornelia Jung, Parisa Javadian-Elyaderani, Stefan Schweyer, Dorothea Schütte, Moneef Shoukier, Feridoun Karimi-Busheri, Michael Weinfeld, Aghdass Rasouli-Nia, Jan G Hengstler, Alejandra Mantilla, Hamid Reza Soleimanpour-Lichaei, Wolfgang Engel, Craig N Robson, Karim Nayernia.
Abstract
Cancer stem cell studies may improve understanding of tumor pathophysiology and identify more effective strategies for cancer treatment. In a variety of organisms, Piwil2 has been implicated in multiple roles including stem cell self-renewal, RNA silencing, and translational control. In this study, we documented specific expression of the stem cell protein Piwil2 in breast cancer with predominant expression in breast cancer stem cells. In patients who were evaluated, we determined that 90% of invasive carcinomas and 81% of carcinomas in situ exhibited highest expression of Piwil2. In breast cancer cells, Piwil2 silencing suppressed the expression of signal transducer and activator of transcription 3, a pivotal regulator of Bcl-X(L) and cyclin D1, whose downregulation paralleled a reduction in cell proliferation and survival. Our findings define Piwil2 and its effector signaling pathways as key factors in the proliferation and survival of breast cancer stem cells. Copyright 2010 AACR.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20460541 DOI: 10.1158/0008-5472.CAN-09-2670
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701